Attention-Deficit/Hyperactivity Disorder: Increased Costs for Patients and Their Families

Swensen, Andrine R.; Birnbaum, Howard G.; Secnik, Kristina; Marynchenko, Maryna; Greenberg, Paul E.; Claxton, Ami J.

doi:10.1097/00004583-200312000-00008

Cited by 157 publications

(115 citation statements)

References 31 publications

Supporting

Mentioning

107

Contrasting

Unclassified

Order By: Relevance

“…2 If left untreated, ADHD may pose a significant barrier to personal development and cause a substantial psychological and financial burden to patients' families. 3 The total economic burden, including direct and indirect costs, associated with ADHD in children and adolescents is estimated to be $42.5 billion (in 2005 U.S. dollars) per year. 4 Results of multiple cost studies consistently indicated that children with ADHD had higher annual medical costs than children without ADHD.…”

Section: Sample Selectionmentioning

confidence: 99%

Comparative Treatment Patterns, Resource Utilization, and Costs in Stimulant-Treated Children with ADHD Who Require Subsequent Pharmacotherapy with Atypical Antipsychotics Versus Non-Antipsychotics

Sikirica¹,

Pliszka²,

Betts³

et al. 2012

JMCP

View full text Add to dashboard Cite

show abstract

Section: Sample Selectionmentioning

confidence: 99%

Comparative Treatment Patterns, Resource Utilization, and Costs in Stimulant-Treated Children with ADHD Who Require Subsequent Pharmacotherapy with Atypical Antipsychotics Versus Non-Antipsychotics

Sikirica¹,

Pliszka²,

Betts³

et al. 2012

JMCP

View full text Add to dashboard Cite

show abstract

“…11 Compared with am atched cohort, ADHD patients had almost 3t imes greater annual health carec osts, and family members had approximately 1.9 times higher annual health caree xpenditures compared with am atched cohort of family members of non-ADHD patients. 12 ADHD in adults is amenable to treatment and is best controlled by ac ombination of medications and psychosocial interventions. 6,13,14 Common medications used for the treatment of ADHD in adults arestimulants (e.g., methylphenidate [MPH], mixed amphetamine salts [MAS], dextroamphetamine) or nonstimulants (e.g., atomoxetine).…”

Section: What This Study Addsmentioning

confidence: 99%

Health Care Costs of Adults Treated for Attention-Deficit/Hyperactivity Disorder Who Received Alternative Drug Therapies

Wu¹,

Birnbaum²,

Zhang³

et al. 2007

JMCP

Self Cite

View full text Add to dashboard Cite

“…Results of medical costs studies showed that children with ADHD had higher annual medical costs than either matched controls (difference ranged from $503 to $1343) or non-matched controls (difference range from $207 to $1560) without ADHD [8]. A limited number of studies have examined other economic implications of ADHD, such as the cost to families, indirect costs associated with work loss among parents of children suffering from ADHD [16,25,26].…”

Section: Introductionmentioning

confidence: 99%

Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD)

Roijen

Zwirs

Bouwmans

et al. 2007

Eur Child Adolesc Psychiatry

111

View full text Add to dashboard Cite

j Abstract Background The impact of attention deficit hyperactive disorder (ADHD) in the Netherlands on health care utilisation, costs and quality of life of these children, as well as of their parents is unknown. Objective The aim of this study was to assess the direct medical costs of patients suffering from ADHD and their quality of life as well as the direct medical costs of their mothers. Study design We selected a group of 70 children who were being treated by a paediatrician for ADHD based on the DSM-IV diagnostic criteria for ADHD. For comparison's sake, we also included a non-matched group of 35 children with behaviour problems and 60 children with no behaviour problem from a large school population-based study on the detection of ADHD. We collected information on the health care utilisation of the children applying the Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness' (TiC-P). Their health related quality of life was collected by using the Dutch 50-item parent version of the Child Health Questionnaire (CHQ PF-50). Measurements were at baseline and at 6 months. Subsequently, we collected data on the health utilisation of the mothers and their production losses due to absence from work and reduced efficiency. Results The mean direct medical costs per ADHD patient per year were e2040 or e1173 when leaving out one patient with a long-term hospital admission, compared to e288 for the group of children with behaviour problems and e177 for the group of children with no behaviour problems. The direct medical costs for children who had psychiatric co-morbidities were significantly higher compared to children with ADHD alone. The mean medical costs per year for the mothers of the ADHD patients were significantly higher than for the mothers of the children with behaviour problems and the mothers of children with no behaviour problems respectively e728, e202 and e154. The physical summary score showed no significant differences between the groups. However, the score on the Psychosocial Summary Score dimension was significantly lower for ADHD patients compared to the scores of the children in the two other samples. The mean annual indirect costs due to absence from work and reduced efficiency at work were e2243 for the mothers of the ADHD patients compared to e408 for the mothers

show abstract

Attention-Deficit/Hyperactivity Disorder: Increased Costs for Patients and Their Families

Cited by 157 publications

References 31 publications

Comparative Treatment Patterns, Resource Utilization, and Costs in Stimulant-Treated Children with ADHD Who Require Subsequent Pharmacotherapy with Atypical Antipsychotics Versus Non-Antipsychotics

Comparative Treatment Patterns, Resource Utilization, and Costs in Stimulant-Treated Children with ADHD Who Require Subsequent Pharmacotherapy with Atypical Antipsychotics Versus Non-Antipsychotics

Health Care Costs of Adults Treated for Attention-Deficit/Hyperactivity Disorder Who Received Alternative Drug Therapies

Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD)

Contact Info

Product

Resources

About